Visit  cricatalyst.com!Nexus — Leaders in Greenhouse Systems Integration Check out more of The Buzz

Fuji building $30million astaxanthin facility in Washington State

July 17, 2013
AlgaeIndustryMagazine.com

President Nishida meets with Washington’s Governor Inslee about the astaxanthin project on July 11th, 2013.

President Nishida meets with Washington’s Governor Inslee about the astaxanthin project on July 11th, 2013.

Fuji Chemical Industry Co. Ltd., AstaReal Technologies Inc., Grant County, and the City of Moses Lake, Washington have announced that AstaReal Technologies Inc. will build a microalgae-based biotechnological manufacturing plant for the production of natural astaxanthin in Moses Lake, WA. During the initial construction phase, $30 million will be invested and 45 permanent local jobs will be created.

Fuji established its manufacturing subsidiary, AstaReal Technologies, Inc., in order to expand its astaxanthin business in the United States, and in the City of Moses Lake in Grant County primarily because of the abundant water resource and competitive costs of renewable hydropower energy. For decades, Grant County International Airport in Moses Lake was home to training operations for Japanese Airlines, the international passenger and cargo carrier. A skilled labor force, an open culture welcoming to Japanese companies, and supportive local and state governments were also contributing factors for the decision to locate in Moses Lake.

AstaReal has been developing its technology for astaxanthin since the 1990s. The natural astaxanthin produced in Moses Lake will be marketed in the United States and worldwide through Fuji’s various subsidiaries. “Astaxanthin is an effective anti-inflammatory agent for living organisms. We want to make people healthier and happier by delivering astaxanthin raw materials for health foods to people across the world.” said Mitsunori Nishida, President and CEO of Fuji Chemical Industry.

“We see the 21st century as the era of anti-aging,” he said. “We believe that preventive medicine will play an even greater role in the future of healthcare as advances in anti-aging, lifestyle and disease research drive improvements both in the treatment and prevention of disease and illness. To that end, we have succeeded in realizing the world’s first industrial production of natural astaxanthin, which is both safe and high in antioxidant potency. We have devoted more efforts than any other research organization in advancing astaxanthin research.”

AstaReal Technologies will produce natural astaxanthin using state of the art photo-bioreactors to cultivate microalgae. The 45 skilled people AstaReal Technologies plans to hire include manufacturing operators, quality control, facilities maintenance and administration. Most employees will be hired locally in mid-2014. The manufacturing plant is anticipated to be completed and start operation in the third quarter of 2014.

President Nishida said, “We are honored to be a community member of Grant County and the City of Moses Lake. We believe that this community will experience significant growth and want to contribute to this future development. This 30 million dollar investment shows our strong commitment to the future of this community.”

Fuji is a global company based near Toyama City in Japan.

More Buzz…

HOME Algae Industry Jobs

Copyright ©2010-2013 AlgaeIndustryMagazine.com. All rights reserved. Permission granted to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

From The A.I.M. Archives

— Refresh Page for More Choices
Chase Ezell writes in Earth911.com about the irony of Algenol’s biggest friction source on the way to marketing their carbon reducing algal-based ethanol being — the EPA ...
Portuguese cement facility, Secil, and microalgae biotechnology company, A4F, also based in Portugal, have formed AlgaFarm, a joint venture to develop the use of cement f...
Biplab Das reports in NatureAsia.com that a research team has found aqueous extracts of the marine brown algae Lobophoro variegate that can inhibit the replication of hum...
James “Jamie” Levine took over the reigns at Sapphire Energy in July of this year as former President and CEO Cynthia “CJ” Warner stepped down, retaining her role as chai...
Algix, parent company of Solaplast, will be inaugurating their algae-to-plastic facility in Meridian, Mississippi, on November 14, 2014. Solaplast's facility will be focu...
Iran-based Qeshm Microalgae Biorefinery Co. (QMAB) has launched a biofuel being marketed as BAYA®, produced from a species of Nannochloropsis (strain 6016) isolated from ...
William Tucker writes in fullfreedom.org about the lure the oceans have for advocates of biofuel, particularly in Scandinavia. “Two-thirds of the globe is covered with wa...
Tess Riley writes in TheGuardian.com about how spirulina may be able to combat malnutrition in developing countries. Spirulina is one of the oldest life forms on Earth, c...
Much of the development of the algae industry in 2014 was driven by domestic and international alliances, partnerships, and mergers that brought complementary skills and ...
Fort Myers, FL-based Algenol, and India's Reliance Industries Ltd., have deployed India’s first Algenol algae production platform. The demonstration module is located nea...
Researchers Greg O’Neil of Western Washington University and Chris Reddy of Woods Hole Oceanographic Institution (WHOI), have exploited an unusual and untapped class of c...
Nutritionaloutlook.com this month gives a well-rounded survey of how algae’s uses in food, beverage, and supplements keep expanding. Here is an excerpt: Thanks to the 201...
A U.S. Department of Energy (DOE) Biomass Energy Technologies Office (BETO) project, awarded to Cal Poly (California Polytechnic State University) in collaboration with M...
Using a malaria parasite protein produced from algae, paired with an immune-boosting cocktail suitable for use in humans, researchers at UC San Diego School of Medicine g...
Solazyme has announced that total revenue for the fourth quarter of 2014 was $14.5 million, compared with $11.3 million in the fourth quarter of 2013, an increase of 29%....